Johnson & Johnson (NYSE:JNJ)
| 159.02 Delayed Data As of 4:00pm ET |  -1.24 / -0.77%Today’s Change | 150.11 Today|||52-Week Range 181.04 | -9.98% Year-to-Date |
Latest JNJ News | Press Releases
Today’s Trading
| Previous close | 160.26 |
| Today’s open | 159.67 |
| Day’s range | 158.86 - 160.09 |
| Volume | 4,904,860 |
| Average volume (3 months) | 17,924,106 |
| Market cap | $386.5B |
Data as of 4:00pm ET, 09/26/2023
Growth & Valuation
| Earnings growth (last year) | -13.84% |
| Earnings growth (this year) | +4.92% |
| Earnings growth (next 5 years) | +3.40% |
| Revenue growth (last year) | +1.34% |
| P/E ratio | 32.3 |
| Price/Sales | 4.95 |
| Price/Book | 5.46 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NONOFNovo Nordisk | -0.53 | -0.57% |
| ABBVAbbVie | -0.69 | -0.45% |
| MRKMerck | -0.44 | -0.42% |
| LLYEli Lilly and Co | -2.45 | -0.44% |
Data as of 4:00pm ET, 09/26/2023
Financials
| Next reporting date | October 17, 2023 |
| EPS forecast (this quarter) | $2.70 |
| Annual revenue (last year) | $95.0B |
| Annual profit (last year) | $17.9B |
| Net profit margin | 18.88% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New Brunswick, New Jersey |
Forecasts
